Education
About Us
Working with TipRanks
Follow Us
Summit Therapeutics (SMMT)
NASDAQ:SMMT
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 0.00 | £ 0.00 | £ 0.00 | £ 704.29K | £ 1.81M |
| Gross Profit | £ -108.36K | £ -15.01M | £ -2.05M | £ -1.81M | £ 1.81M |
| Operating Income | £ -812.24M | £ 313.00K | £ -89.74M | £ -59.63M | £ -86.19M |
| EBITDA | £ -801.12M | £ -212.85M | £ -69.45M | £ -73.12M | £ -85.91M |
| Net Income | £ -1.08B | £ -221.31M | £ -614.93M | £ -78.78M | £ -88.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 713.45M | £ 412.35M | £ 186.24M | £ 348.61M | £ 71.79M |
| Total Assets | £ 751.18M | £ 435.56M | £ 202.95M | £ 664.17M | £ 113.37M |
| Total Debt | £ 15.50M | £ 7.22M | £ 106.10M | £ 518.76M | £ 2.78M |
| Net Debt | £ -209.76M | £ -97.64M | £ 34.67M | £ 170.16M | £ -69.01M |
| Total Liabilities | £ 92.32M | £ 46.81M | £ 125.26M | £ 537.51M | £ 30.09M |
| Stockholders' Equity | £ 658.86M | £ 388.75M | £ 77.69M | £ 126.65M | £ 83.28M |
| Cash Flow | |||||
| Free Cash Flow | £ -323.59M | £ -142.25M | £ -76.89M | £ -42.21M | £ -72.89M |
| Operating Cash Flow | £ -322.93M | £ -142.11M | £ -76.76M | £ -41.58M | £ -72.59M |
| Investing Cash Flow | £ -174.31M | £ -205.34M | £ -587.77M | £ -624.00K | £ -306.00K |
| Financing Cash Flow | £ 617.53M | £ 381.23M | £ 86.51M | £ 620.24M | £ 77.92M |